0001628280-26-032599
SEC filingPhilips shareholders approved all proposals at the 2026 AGM, including appointments and re-appointments to the Supervisory Board and Board of Management, and discharge of board members.
The 2026 AGM approval of all proposals signals strong shareholder support for Philips' governance structure. The appointment of John DeFord adds MedTech expertise in innovation, interventional domains, regulatory, and quality areas, while re-appointments of Paul Stoffels, Herna Verhagen, and Sanjay Poonen ensure continuity. Roy Jakobs' re-appointment as CEO reinforces leadership stability to drive execution, innovation, and strategic priorities amid Philips' focus on health technology. Marc Harrison's departure after eight years concludes his contributions, maintaining board refreshment.